-
Je něco špatně v tomto záznamu ?
Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management
F. Tetart, S. Walsh, B. Milpied, K. Gaspar, A. Vorobyev, GS. Tiplica, B. Didona, A. Welfringer-Morin, V. Kucinskiene, B. Bensaid, E. Marvanova, C. Salavastru, E. Brezinova, SL. Chua, ML. Lovgren, CM. Hammers, A. Barbaud, CG. Mortz, B. Horvath, D....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
PubMed
39023187
DOI
10.1111/jdv.20232
Knihovny.cz E-zdroje
- MeSH
- akutní generalizovaná exantematózní pustulóza * diagnóza etiologie terapie MeSH
- konsensus * MeSH
- lidé MeSH
- přehledová literatura jako téma MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
Acute generalized exanthematous pustulosis (AGEP) is a rare, usually drug-induced, acute pustular rash. Despite the lack of strong data supporting the effectiveness of topical or systemic corticosteroids in this drug reaction, they are widely used. More generally, there is no consensus on the diagnostic modalities and the management of patients with AGEP. We aimed to provide European expert recommendations for the diagnosis and management or patients with AGEP. Members of the ToxiTEN group of the European Reference Network (ERN)-skin, all dermatologists and/or allergologists with expertise in drug reactions, elaborated these recommendations based on their own experience and on a review of the literature. Recommendations were separated into the following categories: professionals involved, assessment of the diagnosis of AGEP, management of the patient and allergological work-up after the acute phase. Consensus was obtained among experts for the list of professionals involved for the diagnosis and management of AGEP, including the minimum diagnostic work-up, the setting of management, the treatments, the modalities and the timing of allergological work-up and follow-up. European experts in drug allergies propose herein consensus on the diagnosis and management of patients with AGEP. A multidisciplinary approach is warranted, including dermatologists, allergologists and pharmacovigilance services.
Birmingham Children's Hospital Birmingham Women's and Children's NHS Foundation Trust Birmingham UK
Center of Rare Diseases IDI IRCCS Rome Rome Italy
Christine Kühne Center for Allergy Research and Education Davos Davos Switzerland
Department of Dermatology and Allergology Charles Nicolle University Hospital Rouen France
Department of Dermatology AP HP Henri Mondor University Hospital Créteil France
Department of Dermatology Christian Albrechts University Kiel Kiel Germany
Department of Dermatology Edouard Herriot University Hospital Lyon France
Department of Dermatology Faculty of Medicine University of Debrecen Debrecen Hungary
Department of Dermatology King's College Hospital London UK
Department of Dermatology Necker Enfants Malades University Hospital Paris France
Department of Dermatology University Hospital of Bordeaux Bordeaux France
Department of Dermatology University Hospital of Zurich Zurich Switzerland
Department of Dermatology University Hospitals Birmingham Birmingham UK
Department of Dermatology University Medical Center Schleswig Holstein Lübeck Germany
Faculty of Medicine University of Zurich Zurich Switzerland
Lübeck Institute of Experimental Dermatology University of Lübeck Lübeck Germany
Regional Pharmacovigilance Centre Pitié Salpêtrière Hospital APHP Sorbonne Université Paris France
ToxiTEN Group European Reference Network for Rare Skin Diseases Paris France
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003722
- 003
- CZ-PrNML
- 005
- 20250206104638.0
- 007
- ta
- 008
- 250121s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jdv.20232 $2 doi
- 035 __
- $a (PubMed)39023187
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Tetart, F $u Department of Dermatology and Allergology, Charles Nicolle University Hospital, Rouen, France $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France
- 245 10
- $a Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management / $c F. Tetart, S. Walsh, B. Milpied, K. Gaspar, A. Vorobyev, GS. Tiplica, B. Didona, A. Welfringer-Morin, V. Kucinskiene, B. Bensaid, E. Marvanova, C. Salavastru, E. Brezinova, SL. Chua, ML. Lovgren, CM. Hammers, A. Barbaud, CG. Mortz, B. Horvath, D. Meyersburg, B. Lebrun-Vignes, C. Bodemer, MC. Brüggen, LE. French, S. Ingen-Housz-Oro
- 520 9_
- $a Acute generalized exanthematous pustulosis (AGEP) is a rare, usually drug-induced, acute pustular rash. Despite the lack of strong data supporting the effectiveness of topical or systemic corticosteroids in this drug reaction, they are widely used. More generally, there is no consensus on the diagnostic modalities and the management of patients with AGEP. We aimed to provide European expert recommendations for the diagnosis and management or patients with AGEP. Members of the ToxiTEN group of the European Reference Network (ERN)-skin, all dermatologists and/or allergologists with expertise in drug reactions, elaborated these recommendations based on their own experience and on a review of the literature. Recommendations were separated into the following categories: professionals involved, assessment of the diagnosis of AGEP, management of the patient and allergological work-up after the acute phase. Consensus was obtained among experts for the list of professionals involved for the diagnosis and management of AGEP, including the minimum diagnostic work-up, the setting of management, the treatments, the modalities and the timing of allergological work-up and follow-up. European experts in drug allergies propose herein consensus on the diagnosis and management of patients with AGEP. A multidisciplinary approach is warranted, including dermatologists, allergologists and pharmacovigilance services.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a akutní generalizovaná exantematózní pustulóza $x diagnóza $x etiologie $x terapie $7 D056150
- 650 12
- $a konsensus $7 D032921
- 650 _2
- $a přehledová literatura jako téma $7 D012196
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Walsh, S $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, King's College Hospital, London, UK $1 https://orcid.org/0000000282790506
- 700 1_
- $a Milpied, B $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France $u Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France $1 https://orcid.org/0000000336796613
- 700 1_
- $a Gaspar, K $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Vorobyev, A $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany $u Department of Dermatology, University Medical Center Schleswig-Holstein, Lübeck, Germany
- 700 1_
- $a Tiplica, G S $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
- 700 1_
- $a Didona, B $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Center of Rare Diseases IDI-IRCCS-Rome, Rome, Italy
- 700 1_
- $a Welfringer-Morin, A $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France $1 https://orcid.org/0000000174793689
- 700 1_
- $a Kucinskiene, V $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno Klinikos, Kaunas, Lithuania
- 700 1_
- $a Bensaid, B $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France $u Department of Dermatology, Edouard Herriot University Hospital, Lyon, France
- 700 1_
- $a Marvanova, E $u Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Salavastru, C $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
- 700 1_
- $a Brezinova, E $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatovenereology, Faculty of Medicine, St. Ann's University Hospital, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Chua, S L $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, University Hospitals Birmingham, Birmingham, UK
- 700 1_
- $a Lovgren, M L $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Birmingham Children's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
- 700 1_
- $a Hammers, C M $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, Christian-Albrechts-University Kiel, Kiel, Germany
- 700 1_
- $a Barbaud, A $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France $u Department of Dermatology and Allergology, Tenon Hospital, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Paris, France $1 https://orcid.org/0000000188891589
- 700 1_
- $a Mortz, C G $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark
- 700 1_
- $a Horvath, B $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, Center for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- 700 1_
- $a Meyersburg, D $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria $1 https://orcid.org/0000000183396917
- 700 1_
- $a Lebrun-Vignes, B $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France $u Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France
- 700 1_
- $a Bodemer, C $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France $u Department of Dermatology, Necker-Enfants Malades University Hospital, Paris, France
- 700 1_
- $a Brüggen, M C $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland $u Faculty of Medicine, University of Zurich, Zurich, Switzerland $u Christine Kühne-Center for Allergy Research and Education Davos (CK-CARE), Davos, Switzerland $1 https://orcid.org/0000000286076254
- 700 1_
- $a French, L E $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany $u Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA $1 https://orcid.org/0000000246291486
- 700 1_
- $a Ingen-Housz-Oro, S $u ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN Skin), Paris, France $u Toxic Bullous Dermatoses and Severe Drug Reactions TOXIBUL Reference Center, AP-HP, Henri Mondor Hospital, Créteil, France $u Department of Dermatology, AP-HP, Henri Mondor University Hospital, Créteil, France $u Univ Paris Est Créteil EpiDermE, Créteil, France $1 https://orcid.org/0000000253837096
- 773 0_
- $w MED00002983 $t Journal of the European Academy of Dermatology and Venereology $x 1468-3083 $g Roč. 38, č. 11 (2024), s. 2073-2081
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39023187 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104633 $b ABA008
- 999 __
- $a ok $b bmc $g 2263472 $s 1239729
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 38 $c 11 $d 2073-2081 $e 20240718 $i 1468-3083 $m Journal of the European Academy of Dermatology and Venereology $n J Eur Acad Dermatol Venereol $x MED00002983
- LZP __
- $a Pubmed-20250121
